A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
Here, we present a protocol that combines in vivo electroporation and denervation of the cranial levator auris longus (LAL) muscle. This procedure enables the study of the potential role of muscle-derived proteins in the regeneration of the neuromuscular synapse.
The neuromuscular junction (NMJ) is the peripheral synapse controlling the contraction of skeletal muscle fibers to allow the coordinated movement of many organisms. At the NMJ, a presynaptic motor axon terminal contacts a muscle postsynaptic domain and is covered by terminal Schwann cells. The integrity and function of the NMJ is compromised under several conditions, including aging, neuromuscular diseases, and traumatic injuries. To analyze the potential contribution of muscle-derived proteins to NMJ maintenance and regeneration, an in vivo gene transfer strategy has been combined with the denervation of the cranial levator auris longus (LAL) muscle after mechanical nerve injury. Previous findings showed that the forced expression of control fluorescent proteins does not alter NMJ organization or neurotransmission. This procedure aims to describe a detailed method of in vivo electroporation of the LAL muscle followed by transection or crushing of the specific branch of the facial nerve innervating cranial muscles, leading to NMJ denervation and reinnervation, respectively. The combination of these experimental strategies in the convenient LAL muscle constitutes an efficient method to study the potential contribution of muscle protein overexpression or silencing in the context of short-term NMJ reinnervation.
The neuromuscular junction (NMJ) is the peripheral synapse that controls muscle contraction and, indirectly, the coordinated movement of organisms1. It is formed by a presynaptic motor axon terminal, a muscle postsynaptic domain enriched in acetylcholine receptors (AChRs), and non-myelinic terminal Schwann cells covering the axon terminal2,3,4. Upon NMJ denervation due to traumatic peripheral nerve injury, disease, or pharmacologic intervention, contractile muscle activity is lost5,6. As certai....
All experimental procedures are approved by the Bioethics Committee at Universidad Austral de Chile, Chile (protocol Nr. 503/2023), and followed the norms imposed by the Bioethics Committee of the National Research and Development Agency, Chile (ANID), as well as the guidelines of the European Council Directive for the Care of Laboratory Animals. The present study used adult (3-6 months old) CF-1 mice of both sexes (30-45 g). Euthanasia was accomplished by inhalant anesthetic overdose followed by exsanguination. The reagents and equipment used in the study are listed in the Table of Materials.
1. In vivo LAL....
The high fluorescence quantum yield of the tdTomato protein20 makes it an appropriate tracer for electroporation efficiency. Therefore, the expression of tdTomato protein in LAL muscles by in vivo electroporation was evaluated (Figure 1). LAL muscles were dissected 21 days after electroporation. Whole-mount preparations show the thin caudal band (cLAL, cyan polygon) of the LAL muscle with its two innervation regions, and the thick rostral band (rLAL, yellow p.......
The combination of in vivo muscle electroporation and denervation is a valuable experimental approach to investigating a regenerative niche at the NMJ4. Since the LAL muscle is superficially exposed, these combined procedures can be readily complemented with the delivery of probes or drugs that could affect protein expression or activity12. In addition, electroporation of reporter genes into the LAL muscle could provide a valuable tool to follow the activation or i.......
The authors have nothing to disclose.
We thank the highly collaborative and stimulating environment of the NeSt Lab members for useful discussion and comments on this work. Work at the NeSt Lab is currently funded by FONDECYT 1221213. The scheme in Figure 1A was created with BioRender.com.
....Name | Company | Catalog Number | Comments |
#5/45 Dumont forceps | Fine Science Tools | 11251-35 | Sterilize before use |
anti 2H3 | DSHB | Dilute 1 : 300 | |
anti S100 Ready to Use | Dako | IR504 | Dilute 1 : 5 |
anti SV2 | DSHB | Dilute 1 : 50 | |
Chlorhexidine gluconate 2% | DifenPharma | ||
Cold light dissecting stereomicroscope | Motic | Model SMZ-171 | |
DAPI | Invitrogen | D1306 | Dilute 1 : 100 |
Dumont #5SF Forceps | Fine Science Tools | 11252-00 | Sterilize before use |
Dumont Mini Forceps –Style 5 | Fine Science Tools | 11200-14 | Sterilize before use |
ECM 830 electroporator | BTX Harvard Apparatus | ||
Gold needle-type electrodes | Genetrodes, BTX | 45-0114 | 10 mm straight |
Hamilton syringe | Hamilton | 80400 | |
Hyaluronidase | Sigma-Aldrich | H3884 | |
Inhalation anesthesia machine | SciVerma Scientific | M3000 Table Top | |
Isoflurane | Baxter | 218-082 | |
Mice | Instituto de Salud Publica - Chile | Adult (3-6 months old) CF-1 mice, of both sexes (30-45 g) | |
Razor blades | Schick | ||
Suture Glicosorb 5/0 | TAGUM | GS0812.J | Absorbable polyglycolic acid thread |
tdTomato plasmid | Addgene | 54642 | tdTomato plasmid under the control of the CMV promoter |
Tramadol hydrochloride 5% (Triamcol) | Drag Pharma | ||
Vannas Spring Scissors | Fine Science Tools | 91500-09 | Sterilize before use |
WGA Alexa Fluor 488 | Invitrogen | W7024 | Dilute |
α-BTX Alexa Fluor 488 | Invitrogen | B13422 | Dilute 1 : 500 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved